386 related articles for article (PubMed ID: 36901885)
1. Biodegradable Polymeric Nanoparticles Loaded with Flavonoids: A Promising Therapy for Inflammatory Bowel Disease.
Li M; Liu Y; Weigmann B
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901885
[TBL] [Abstract][Full Text] [Related]
2. Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases.
Zu M; Ma Y; Cannup B; Xie D; Jung Y; Zhang J; Yang C; Gao F; Merlin D; Xiao B
Adv Drug Deliv Rev; 2021 Sep; 176():113887. PubMed ID: 34314785
[TBL] [Abstract][Full Text] [Related]
3. Small but powerful: will nanoparticles be the future state-of-the-art therapy for IBD?
Lechner K; Zeeshan M; Noack M; Ali H; Neurath MF; Weigmann B
Expert Opin Drug Deliv; 2022 Mar; 19(3):235-245. PubMed ID: 35184617
[TBL] [Abstract][Full Text] [Related]
4. Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD).
Kumar J; Newton A
Antiinflamm Antiallergy Agents Med Chem; 2016; 15(2):101-117. PubMed ID: 27449742
[TBL] [Abstract][Full Text] [Related]
5. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD).
Kumar J; Newton AMJ
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):41-52. PubMed ID: 28034350
[TBL] [Abstract][Full Text] [Related]
6. The future of nanomedicine in optimising the treatment of inflammatory bowel disease.
Mohan LJ; Daly JS; Ryan BM; Ramtoola Z
Scand J Gastroenterol; 2019 Jan; 54(1):18-26. PubMed ID: 30678499
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles Derived from the Natural Antioxidant Rosmarinic Acid Ameliorate Acute Inflammatory Bowel Disease.
Chung CH; Jung W; Keum H; Kim TW; Jon S
ACS Nano; 2020 Jun; 14(6):6887-6896. PubMed ID: 32449857
[TBL] [Abstract][Full Text] [Related]
8. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease.
Chen F; Liu Q; Xiong Y; Xu L
Int J Nanomedicine; 2021; 16():4225-4237. PubMed ID: 34188471
[TBL] [Abstract][Full Text] [Related]
9.
Musumeci L; Maugeri A; Cirmi S; Lombardo GE; Russo C; Gangemi S; Calapai G; Navarra M
Nat Prod Res; 2020 Jan; 34(1):122-136. PubMed ID: 30990326
[TBL] [Abstract][Full Text] [Related]
10. Orally administered covalently-assembled antioxidative peptide nanoparticles for inflammatory bowel disease therapy.
Ma X; Gong H; Liu Y; Liu Y; Ogino K; Xing R; Yan X
J Colloid Interface Sci; 2022 Nov; 626():156-166. PubMed ID: 35780549
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease.
Li DF; Yang MF; Xu HM; Zhu MZ; Zhang Y; Tian CM; Nie YQ; Wang JY; Liang YJ; Yao J; Wang LS
J Mater Chem B; 2022 Aug; 10(31):5853-5872. PubMed ID: 35876136
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids in Inflammatory Bowel Disease: A Review.
Vezza T; RodrÃguez-Nogales A; Algieri F; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
Nutrients; 2016 Apr; 8(4):211. PubMed ID: 27070642
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
Yang C; Merlin D
Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
[TBL] [Abstract][Full Text] [Related]
14. Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review.
Cui M; Zhang M; Liu K
Carbohydr Polym; 2021 Nov; 272():118530. PubMed ID: 34420762
[TBL] [Abstract][Full Text] [Related]
15. Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review.
Zarenezhad E; Abdulabbas HT; Kareem AS; Kouhpayeh SA; Barbaresi S; Najafipour S; Mazarzaei A; Sotoudeh M; Ghasemian A
Arch Microbiol; 2023 May; 205(6):252. PubMed ID: 37249707
[TBL] [Abstract][Full Text] [Related]
16. Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease.
Truffi M; Sevieri M; Morelli L; Monieri M; Mazzucchelli S; Sorrentino L; Allevi R; Bonizzi A; Zerbi P; Marchini B; Longhi E; Sampietro GM; Colombo F; Prosperi D; Colombo M; Corsi F
Int J Nanomedicine; 2020; 15():8537-8552. PubMed ID: 33173291
[TBL] [Abstract][Full Text] [Related]
17. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
[TBL] [Abstract][Full Text] [Related]
18. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease.
Zeeshan M; Ali H; Khan S; Khan SA; Weigmann B
Int J Pharm; 2019 Mar; 558():201-214. PubMed ID: 30615925
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory Effects of Flavonoids in the Prophylaxis and Treatment of Inflammatory Bowel Diseases: A Comprehensive Review.
Ribeiro D; Proenca C; Rocha S; Lima JLFC; Carvalho F; Fernandes E; Freitas M
Curr Med Chem; 2018; 25(28):3374-3412. PubMed ID: 29446723
[TBL] [Abstract][Full Text] [Related]
20. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
